Submission Details
| 510(k) Number | K240967 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 09, 2024 |
| Decision Date | July 31, 2024 |
| Days to Decision | 113 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K240967 is an FDA 510(k) clearance for the ValvuloPro Valvuloplasty Balloon Catheter, a Balloon Aortic Valvuloplasty (Class II — Special Controls, product code OZT), submitted by Dongguan TT Medical, Inc. (Dongguan, CN). The FDA issued a Cleared decision on July 31, 2024, 113 days after receiving the submission on April 9, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1255.
| 510(k) Number | K240967 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 09, 2024 |
| Decision Date | July 31, 2024 |
| Days to Decision | 113 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | OZT — Balloon Aortic Valvuloplasty |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1255 |
| Definition | A Balloon Aortic Valvuloplasty Catheter Is Indicated For Balloon Valvuloplasty Of The Aortic Valve. |